|1.||Wang, Yun: 4 articles (10/2014 - 10/2010)|
|2.||Kong, Shuzhen: 4 articles (10/2014 - 10/2010)|
|3.||Wan, Li: 2 articles (10/2014 - 05/2011)|
|4.||Liu, Jianhui: 2 articles (01/2014 - 10/2010)|
|5.||Qian, Binbin: 2 articles (05/2011 - 10/2010)|
|6.||Dargham, Raya Abou: 1 article (10/2014)|
|7.||Cheng, Longzhen: 1 article (10/2014)|
|8.||Ren, Wanting: 1 article (10/2014)|
|9.||Liu, Xu: 1 article (10/2014)|
|10.||Wu, Zheng: 1 article (10/2014)|
|1.||Hypertension (High Blood Pressure)
01/01/1985 - "Comparison of cyclothiazide and hydrochlorthiazide in hypertension. "
08/26/1977 - "Three dosage combinations of clonidine and cyclothiazide were tested in at least 20 patients each, under clinical (4 weeks) and oupatients (longterm) conditions, in order to find a suitable combination with fewer side effects than the single drugs with at least equal efficacy for the longterm treatment of hypertension. "
11/30/1983 - "[Clonidine-cyclothiazide combination in the therapy of arterial hypertension. "
02/28/1981 - "[Short-term clinical trial of a clonidine-cyclothiazide combination in the treatment of arterial hypertension]."
02/01/1979 - "Cyclothiazide and atenolol once daily in essential hypertension."
05/01/2011 - "We have previously reported that cyclothiazide (CTZ) evokes epileptiform activities in hippocampal neurons and induces seizure behavior. "
10/08/2010 - "Cyclothiazide induces seizure behavior in freely moving rats."
12/01/2006 - "Cyclothiazide prolongs low [Mg2+]-induced seizure-like events."
01/01/2005 - "Cyclothiazide alone did not evoke seizures. "
10/01/2014 - "In this study, we used cyclothiazide (CTZ)-induced in vitro brain slice seizure model to explore the effect of selective activation of extrasynaptic GABA(A)Rs by 4,5,6,7-tetrahydroisoxazolo[5,4-c] pyridine-3-ol (THIP) on the CTZ-induced epileptiform activity in hippocampal neurons. "
05/01/2004 - "The novel finding of this study is that carrageenan-induced inflammation, in the presence of cyclothiazide, an inhibitor of AMPA receptor desensitization, produces a sustained facilitation of the AMPA-mediated membrane current and rises in [Ca2+]i in both the soma and proximal dendrites of SG neurons recorded on the injected side 3 h after the induction of inflammation. "
|4.||Ganglion Cysts (Ganglion)
09/01/1999 - "To measure the output of transient amacrine cells, we recorded glycinergic inhibitory postsynaptic currents (IPSCs) from ganglion cells, and found that these were also enhanced by cyclothiazide. "
09/01/1995 - "Cyclothiazide also enhanced the amplitude and duration of both the ON and OFF light-evoked (L-) EPSCs recorded in ON-OFF ganglion cells. "
03/01/1999 - "In control solution, blocking AMPA receptor desensitization with cyclothiazide (80-100 microM) greatly reduced the light responses of ON-OFF DS ganglion cells. "
09/01/1995 - "Cyclothiazide selectively enhanced the AMPA/KA receptor-mediated component of ganglion cells EPSCs, suggesting that desensitization of AMPA/KA receptors shape transient L-EPSCs."
09/01/2001 - "Both cyclothiazide (10 microM-100 microM) and the novel drug 4-[2-(phenylsulfonylamino)ethylthio]-2,6-difluoro-phenoxyacetamide (PEPA, 20 microM-100 microM), which selectively enhance responses mediated by AMPA-preferring receptors, enhanced glutamate-induced responses of ganglion cells. "
|5.||Nephrogenic Diabetes Insipidus
|1.||Clonidine (ST 155)
|2.||alpha- Amino- 3- hydroxy- 5- methyl- 4- isoxazolepropionic Acid (AMPA)
|3.||AMPA Receptors (AMPA Receptor)
|4.||gamma-Aminobutyric Acid (GABA)
|7.||4,5,6,7- tetrahydroisoxazolo(5,4- c)pyridin- 3- ol (THIP)
|9.||Glutamic Acid (Glutamate)